Gerhards, C., Thiaucourt, M., Hetjens, M., Haselmann, V., Neumaier, M., & Kittel, M. (2023). Heterologous vector-mRNA based SARS-CoV-2 vaccination strategy appears superior to a homologous vector-based vaccination scheme in German healthcare workers regarding humoral SARS-CoV-2 response indicating a high boosting effect by mRNA vaccines. Vaccines, 11(3), . https://doi.org/10.3390/vaccines11030701
Chicago-Zitierstil (17. Ausg.)Gerhards, Catharina, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier, und Maximilian Kittel. "Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by MRNA Vaccines." Vaccines 11, no. 3 (2023). https://doi.org/10.3390/vaccines11030701.
MLA-Zitierstil (9. Ausg.)Gerhards, Catharina, et al. "Heterologous Vector-mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector-based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by MRNA Vaccines." Vaccines, vol. 11, no. 3, 2023, https://doi.org/10.3390/vaccines11030701.